Pharmaceutical Services

The Pharmaceutical Services section of the Health Protection Service (HPS) ensures the safe supply of medicines, poisons and therapeutic goods to the ACT community.

The Pharmaceutical Services section of the Health Protection Service (HPS) ensures the safe supply of medicines, poisons and therapeutic goods to the ACT community.

We are responsible for conducting various regulatory activities that help ensure medicines or poisons are prescribed, stored and supplied in line with local legislation. This includes responsibly regulating community pharmacy ownership and premises in the ACT.

We also distribute information about medicines and therapeutic goods recalls across the ACT community to ensure their protection from any harm associated with the use of sub-standard or unsafe products.

For more information, please contact us on 02 6205 0998 or hps@act.gov.au

Our postal address is: Pharmaceutical Services, Health Protection Service Locked Bag 5005, Weston Creek ACT 2611. Fax 02 6205 0997

Find us at Howard Florey Centenary House, 25 Mulley street, Holder ACT 2611

Banned sports substances

It has come to the attention of the Health Protection Service (HPS) that sports supplements labelled as containing banned substances are being sold in the ACT primarily through retail supplement stores.

Banned substances include selective androgen receptor modulators (SARMs), cardarine, tadalafil, oxedrine, melatonin, clomifene, l-dopa, DHEA and phenibut. These substances are associated with important health and safety concerns.

It is illegal for supplement stores to supply these banned substances. It is also illegal for consumers to possess some of these substances without a prescription.

If you are taking a supplement which is labelled as containing a banned substance, you should stop taking it immediately. If you are concerned about your health, please contact your general practitioner.

The HPS is currently investigating this issue further and will be testing a number of products. If you have information to support this investigation, please contact the Pharmaceutical Services Section of the HPS on (02) 6205 0998.

Attachments
Page last updated on: 3 Dec 2018